Rita Jain

SVP, Chief Medical Officer, Akebia Therapeutics, Inc.

Companies

First Tracks Biotherapeutics, Inc.Board member Apr 1, 2026 to now¹
SAB Biotherapeutics, Inc.Board member Jan 7, 2026 to now²
Avalo Therapeutics, Inc.Board member Jun 18, 2025 to now³
ANAPTYSBIO, INCBoard member Apr 6, 2023 to now⁴
Celldex TherapeuticsBoard member Feb 21, 2023 to now⁵
Provention Bio, Inc.Board member Jan 5, 2023 to Apr 27, 2023⁶
ChemoCentryx, Inc.EVP, Chief Medical Officer Oct 7, 2021 to Oct 24, 2022⁷
ChemoCentryx, Inc.Board member Mar 29, 2019 to Oct 24, 2022⁸
Immunovant, Inc.Chief Medical Officer Jan 14, 2021 to Mar 31, 2021⁹
Akebia Therapeutics, Inc.SVP, Chief Medical Officer Jun 1, 2017 to Apr 12, 2019¹⁰

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

First Tracks Biotherapeutics, Inc. TRAX19,194 shares¹¹$694.6K at $36.19Jun 15, 2026
ANAPTYSBIO, INC ANAB11,864 shares¹²$562.6K at $47.42Jun 15, 2025
ChemoCentryx, Inc.0 shares¹³Oct 20, 2022

As of each latest filing. The line shows shares held over time.

Jun 15, 2026Exercised options 7,330 shares of First Tracks Biotherapeutics, Inc.¹¹
Jun 15, 2025Exercised options 7,330 shares of ANAPTYSBIO, INC¹²
Jun 15, 2024Exercised options 4,534 shares of ANAPTYSBIO, INC¹⁴
Oct 20, 2022Returned to company 35,863 shares of ChemoCentryx, Inc.¹³
May 20, 2022Exercised options 7,726 shares of ChemoCentryx, Inc.¹⁵
Mar 27, 2022Exercised options 5,251 shares of ChemoCentryx, Inc.¹⁶

The numbers on this page point here. Each one links to the record it came from.